{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:10:13Z","timestamp":1781010613543,"version":"3.54.1"},"reference-count":24,"publisher":"SLACK, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychosoc Nurs Ment Health Serv"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:p>The hypothalamic-pituitary-adrenal (HPA) axis is the body\u2019s main stress-response system, and cortisol is the major adrenal glucocorticoid hormone secreted in human beings. HPA axis activity and cortisol secretion is regulated by a negative feedback system involving glucocorticoid receptors. Dysregulation of the HPA axis and increased cortisol levels have been implicated in mood, psychotic, and other psychiatric disorders. Mifepristone, as a potent antagonist of glucocorticoid receptors, has been studied or is currently being investigated as a potential therapeutic agent for psychotic depression, posttraumatic stress disorder, and alcohol and cocaine dependence, as well as for mitigating the weight gain associated with the use of antipsychotic drugs and for improving cognitive dysfunction in schizophrenia and bipolar disorder. This article will review some of the work in these areas.<\/jats:p>","DOI":"10.3928\/02793695-20130513-01","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T18:06:54Z","timestamp":1370455614000},"page":"11-14","source":"Crossref","is-referenced-by-count":18,"title":["Mifepristone as a Therapeutic Agent in Psychiatry"],"prefix":"10.3928","volume":"51","author":[{"given":"Robert H.","family":"Howland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01185.x"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12031-002-0033-3"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182239191"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2009.03.001"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573400511309020009"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.05.034"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2006.09.038"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006205-199406000-00014"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-7443(03)80055-8"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2007.12.005"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2004.10.017"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/393251"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-009-0070-1"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2010.51"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20061201-08"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10357"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(97)00189-1"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1202"},{"key":"e_1_3_1_20_1","first-page":"563","article-title":"Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression","volume":"8","author":"Nihalani N.D.","year":"2007","unstructured":"Nihalani N.D., Schwartz T.L. (2007). Mifepristone, a glucocorticoid antagonist for the potential treatment of psychotic major depression. Current Opinion in Investigational Drugs, 8, 563\u2013569.","journal-title":"Current Opinion in Investigational Drugs"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.9.1436"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0b013e31820ad12b"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2008.00131.x"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.02.016"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2012.05.029"}],"container-title":["Journal of Psychosocial Nursing and Mental Health Services"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/02793695-20130513-01","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:04:10Z","timestamp":1683072250000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/02793695-20130513-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.3928\/02793695-20130513-01"],"URL":"https:\/\/doi.org\/10.3928\/02793695-20130513-01","relation":{},"ISSN":["0279-3695","1938-2413"],"issn-type":[{"value":"0279-3695","type":"print"},{"value":"1938-2413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}